Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic Solution



Status:Terminated
Healthy:No
Age Range:18 - 79
Updated:4/21/2016
Start Date:April 2012
End Date:December 2015

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
The patients included will be those who have already agreed to have a brachial plexus nerve
block for surgery. A flip of the coin will decide who gets and additive called buprenorphine
in their block or not. They will both contain the same amount and type of numbing medicine.
The goal will be to see if the additive extends the life of the pain control portion of the
ultrasound guided supraclavicular nerve block.


Inclusion Criteria:

1. American Society of Anesthesiologists (ASA) physical status 1-3

2. Age 18-79, inclusive

3. BMI <36 kg/m^2

4. Patient consenting to single injection brachial plexus nerve block as primary
anesthetic for a procedure

Exclusion Criteria:

1. Patients with coagulation disorders

2. Clinically significant pulmonary disease

3. Clinically significant cardiac disease

4. Neurologic deficit in surgical extremity

5. Allergy to bupivacaine or buprenorphine

6. Intolerance of narcotics

7. Local infection over intended area of needle insertion

8. Hepatic failure or renal failure

9. Significant psychiatric disease, including drug abuse

10. Seizure disorder

11. Possible pregnancy or lactation by patient report

12. Use of narcotic medication greater than 2 times a week for greater than 1 week.

13. Patients for whom the surgeon requests a shorter-acting block
We found this trial at
1
site
University of Wisconsin
Madison, Wisconsin 53792
(608) 263-2400
University of Wisconsin In achievement and prestige, the University of Wisconsin–Madison has long been recognized...
?
mi
from
Madison, WI
Click here to add this to my saved trials